ID: ALA5268044

Max Phase: Preclinical

Molecular Formula: C154H222BBrF4N36O20

Molecular Weight: 3064.41

Associated Items:

Representations

Canonical SMILES:  CC[C@@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCc1ccccc1)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)CCc1cn(CCN2CCCc3cc(/C=C/C4=C(Br)C(/C=C/c5cc6c7c(c5)CCCN7CCC6)=[O+][B-](F)(C(F)(F)F)O4)ccc32)nn1)C1CCCCC1)[C@H](C)CC)C1CCCCC1)[C@H](C)CC)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C154H222BBrF4N36O20/c1-9-94(6)128(146(211)184-119(69-60-98-39-18-13-19-40-98)137(202)179-116(53-31-77-173-151(166)167)139(204)188-130(96(8)11-3)147(212)186-121(90-100-57-66-111(197)67-58-100)143(208)177-112(134(163)199)68-59-97-37-16-12-17-38-97)187-138(203)114(51-27-29-75-162)183-149(214)132(105-44-22-15-23-45-105)191-141(206)118(55-33-79-175-153(170)171)181-145(210)129(95(7)10-2)189-144(209)122(91-102-56-64-103-41-24-25-46-106(103)87-102)185-136(201)115(52-30-76-172-150(164)165)178-135(200)113(50-26-28-74-161)182-148(213)131(104-42-20-14-21-43-104)190-140(205)117(54-32-78-174-152(168)169)180-142(207)120(85-93(4)5)176-126(198)73-65-110-92-196(193-192-110)84-83-194-80-34-47-107-86-99(61-70-123(107)194)62-71-124-127(156)125(216-155(160,215-124)154(157,158)159)72-63-101-88-108-48-35-81-195-82-36-49-109(89-101)133(108)195/h12-13,16-19,24-25,37-41,46,56-58,61-64,66-67,70-72,86-89,92-96,104-105,112-122,128-132,197H,9-11,14-15,20-23,26-36,42-45,47-55,59-60,65,68-69,73-85,90-91,161-162H2,1-8H3,(H2,163,199)(H,176,198)(H,177,208)(H,178,200)(H,179,202)(H,180,207)(H,181,210)(H,182,213)(H,183,214)(H,184,211)(H,185,201)(H,186,212)(H,187,203)(H,188,204)(H,189,209)(H,190,205)(H,191,206)(H4,164,165,172)(H4,166,167,173)(H4,168,169,174)(H4,170,171,175)/b71-62+,72-63+/t94-,95-,96-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,128-,129-,130-,131-,132-,155?/m1/s1

Standard InChI Key:  TXGITVRMXSNYMY-WNXUKHPPSA-N

Associated Targets(Human)

Growth/differentiation factor 8 196 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Amyloid-beta A4 protein 8510 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Chymotrypsin 134 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypsin 2137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK293 82097 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3064.41Molecular Weight (Monoisotopic): 3061.6674AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Okamoto H, Murano SA, Ikekawa K, Katsuyama M, Konno S, Taguchi A, Takayama K, Taniguchi A, Hayashi Y..  (2023)  Inactivation of myostatin by photooxygenation using functionalized d-peptides.,  14  (2.0): [PMID:36846372] [10.1039/d2md00425a]

Source